ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,081, issued on Feb. 4, was assigned to Oblita Therapeutics BVBA (Zoersel, Belgium).
"Tablet dosage formulations of oleyl phosphocholine" was invented by Johannes Jan Platteeuw (Werkhoven, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to tablet dosage formulations of oleyl phosphocholine for oral administration and the processes for their preparation. Specifically, the present invention provides a process for preparing an oleyl phosphocholine containing granulate, said process comprising a blending step, a hot melt agglomeration step and a milling step. The present invention further provides a process for pre...